ObsEva SA [NASDAQ: OBSV] closed the trading session at $2.63 on 07/28/21. The day’s price range saw the stock hit a low of $2.61, while the highest price level was $2.84. The company report on July 27, 2021 that Organon and ObsEva Enter Global License Agreement to Develop and Commercialize Ebopiprant (OBE022), an Investigational Agent Being Evaluated as a First-in-Class Treatment for Preterm Labor.
Every year, an estimated 15 million babies are born preterm (before 37 completed weeks of gestation) i; agent is being studied in an area of significant unmet need.
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange.
The stocks have a year to date performance of 26.44 percent and weekly performance of -1.50 percent. The stock has been moved at -24.21 percent over the last six months. The stock has performed -13.77 percent around the most recent 30 days and changed -18.58 percent over the most recent 3-months.
If compared to the average trading volume of 1.76M shares, OBSV reached to a volume of 4368898 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about ObsEva SA [OBSV]:
JP Morgan have made an estimate for ObsEva SA shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on November 09, 2020. While these analysts kept the previous recommendation, JP Morgan raised their target price from $18 to $5. The new note on the price target was released on July 07, 2020, representing the official price target for ObsEva SA stock. Previously, the target price had yet another drop from $5 to $4, while BMO Capital Markets kept a Market Perform rating on OBSV stock. On November 08, 2019, analysts decreased their price target for OBSV shares from 16 to 4.
The Average True Range (ATR) for ObsEva SA is set at 0.19, with the Price to Sales ratio for OBSV stock in the period of the last 12 months amounting to 8226.36. The Price to Book ratio for the last quarter was 3.65, with the Price to Cash per share for the same quarter was set at 1.14.
OBSV stock trade performance evaluation
ObsEva SA [OBSV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.50. With this latest performance, OBSV shares dropped by -13.77% in over the last four-week period, additionally sinking by -24.21% over the last 6 months – not to mention a drop of -0.38% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OBSV stock in for the last two-week period is set at 45.06, with the RSI for the last a single of trading hit 46.38, and the three-weeks RSI is set at 44.87 for ObsEva SA [OBSV]. The present Moving Average for the last 50 days of trading for this stock 2.87, while it was recorded at 2.61 for the last single week of trading, and 2.87 for the last 200 days.
ObsEva SA [OBSV]: An insightful look at the core fundamentals
Return on Total Capital for OBSV is now -143.21, given the latest momentum, and Return on Invested Capital for the company is -150.82. Return on Equity for this stock declined to -289.54, with Return on Assets sitting at -97.96. When it comes to the capital structure of this company, ObsEva SA [OBSV] has a Total Debt to Total Equity ratio set at 322.58. Additionally, OBSV Total Debt to Total Capital is recorded at 76.34, with Total Debt to Total Assets ending up at 41.18. Long-Term Debt to Equity for the company is recorded at 314.24, with the Long-Term Debt to Total Capital now at 74.36.
Reflecting on the efficiency of the workforce at the company, ObsEva SA [OBSV] managed to generate an average of -$1,942,998 per employee.ObsEva SA’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.30 and a Current Ratio set at 4.30.
ObsEva SA [OBSV]: Insider Ownership positions
There are presently around $46 million, or 38.10% of OBSV stock, in the hands of institutional investors. The top three institutional holders of OBSV stocks are: SOFINNOVA INVESTMENTS, INC. with ownership of 4,749,623, which is approximately 0% of the company’s market cap and around 6.80% of the total institutional ownership; NEA MANAGEMENT COMPANY, LLC, holding 4,586,563 shares of the stock with an approximate value of $12.06 million in OBSV stocks shares; and MEDICXI VENTURES MANAGEMENT (JERSEY) LTD, currently with $4.13 million in OBSV stock with ownership of nearly 0% of the company’s market capitalization.
Positions in ObsEva SA stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 27 institutional holders increased their position in ObsEva SA [NASDAQ:OBSV] by around 1,425,258 shares. Additionally, 20 investors decreased positions by around 3,175,496 shares, while 8 investors held positions by with 13,041,675 shares. The mentioned changes placed institutional holdings at 17,642,429 shares, according to the latest SEC report filing. OBSV stock had 15 new institutional investments in for a total of 690,678 shares, while 9 institutional investors sold positions of 908,298 shares during the same period.